Finding opportunities in Biotech ER or buy-side to exit medicine

I have a long personal story on how I arrived here, but it's definitely not novel just from browsing the forums here: new doctor looking to leave medicine for finance. 

I am a recently-started surgical preliminary intern (applied to a surgical subspecialty and didn't match) looking to exit medicine. I became very disenchanted with the process and, while I believe I have a strong enough application to reapply or even change specialties, the long-term upside doesn't really seem worth destroying my mental in the process. The love of medicine and patient care just don't outweigh having to endure the training process for me.  To be clear, I am not afraid of working long hours and had very much accepted that I'd be putting in my ACGME-regulated "80 hours" for the next 5 to 6 years; it's just that the long-term goal doesn't seem worth it anymore (culture, industry trends, opportunity cost), especially starting residency at 30. 

I got the idea of looking into biotech equity research and biotech-focused hedge funds from family working in finance as a potential pivot to leverage my educational background (ivy league undergrad, meh med school) and my research resume for recruiting. My understanding of the day-to-day of being an ER associate or analyst is that it's fairly similar to how I spent my research year (which I enjoyed).

Through some personal networking, I've connected and chatted with individuals at a couple biotech-focused hedge funds and got some general ideas.  However, I still feel lost about what competencies I should be honing or developing, how to develop them, and where to look for opportunities to break in. Like trying to develop a stock pitch without any guidance has been difficult even though I've enjoyed learning about some companies and the indications they are targeting.  

If anybody has similar experience, I'd be very grateful to connect for some guidance. Thank you! 

4 Comments
 

Based on the most helpful WSO content, here are some insights and advice for transitioning from medicine to biotech equity research (ER) or the buy-side:

Exit Opportunities in Biotech ER or Buy-Side

  1. Competencies to Develop:

    • Financial Analysis Skills: Understanding financial statements, valuation techniques, and financial modeling is crucial. Consider taking courses or certifications in these areas.
    • Industry Knowledge: Deepen your understanding of the biotech and pharmaceutical industries, including drug development processes, regulatory environments, and market dynamics.
    • Stock Pitch Development: Practice creating and presenting stock pitches. This involves analyzing a company's financial health, market position, and growth potential.
  2. Educational Background:

    • Your Ivy League undergraduate education and medical school background are strong assets. Highlight these in your applications and networking efforts.
    • Consider pursuing an MBA or relevant certifications (e.g., CFA) to bolster your finance credentials.
  3. Networking:

    • Continue leveraging personal connections in finance. Networking is key in breaking into ER or buy-side roles.
    • Attend industry conferences, webinars, and networking events to meet professionals in biotech finance.
  4. Practical Experience:

    • Seek internships or part-time roles in biotech ER or at biotech-focused hedge funds to gain hands-on experience.
    • Engage in independent research projects or contribute to finance-related publications to build your resume.
  5. Resources and Guidance:

    • Utilize forums like Wall Street Oasis to connect with individuals who have made similar transitions. They can provide valuable insights and mentorship.
    • Look for guides and resources on evaluating biotech companies, as these can provide frameworks and methodologies for your analyses.

Additional Insights from WSO Threads:

  • Doctor Thinking of Exit Opportunities: Physicians have successfully transitioned to equity research or management consulting in biotech/pharma/healthcare. The analytical and critical thinking skills developed in medicine are highly valued in these roles.
  • 2nd Year Biotech Equity Research Looking for Next Steps: Transitioning from ER to healthcare banking or buy-side roles is feasible, especially with a strong science background. Networking and gaining relevant experience are crucial steps.

By focusing on these areas, you can effectively pivot from medicine to a career in biotech equity research or the buy-side. Good luck!

Sources: Doctor thinking of exit opportunities, 2nd yr Biotech Equity Research looking for next steps......, Biotech equity research possible with ZERO finance experience?, Feel Trapped, Exit Opps From Sell-Side ER?, Where does ER go from here?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Reiciendis suscipit quia itaque voluptas est omnis similique non. Ut ipsam possimus eos rerum et exercitationem. Reiciendis quod fugit facilis esse eius aut. Ut veritatis vitae asperiores odio.

Vitae dolores officia ipsam omnis ut facere possimus. Nesciunt et enim quasi blanditiis repellat.

 

Ullam voluptatem cumque sed et nemo beatae incidunt. Optio ullam facilis aperiam fuga est. Est eius consectetur nulla quia ut.

Fugit atque aliquam occaecati facere unde. Nobis voluptatem unde maiores explicabo maxime quia tempora veniam. Ullam laboriosam in enim exercitationem et.

Alias qui odio magnam quam ullam. Illo dolorem sequi nemo. Ad harum et aspernatur doloremque sit veritatis. Quia et voluptatem id blanditiis qui sapiente.

Autem quo odit sunt quia ab. Corporis error voluptas facere rerum reprehenderit odio. Eveniet quis delectus provident.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”